Coherent (COHR) Tops Q2 EPS by 5c

Coherent (NASDAQ: COHR) reported Q2 EPS of $1.04, $0.05 better than the analyst estimate of $0.99. Revenue for the quarter came in at $199.9 million versus the consensus estimate of $197.44 million.

For earnings history and earnings-related data on Coherent (COHR) click here.

You May Also Be Interested In

• Coherent (COHR) PT Raised to $420 at Needham
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c